Pulp Washing Equipment Market
Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: ... Read More
Pulmonary Surfactant Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PULMONARY SURFACTANT INDUSTRY
2.1 Summary about Pulmonary Surfactant Industry
2.2 Pulmonary Surfactant Market Trends
2.2.1 Pulmonary Surfactant Production & Consumption Trends
2.2.2 Pulmonary Surfactant Demand Structure Trends
2.3 Pulmonary Surfactant Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Synthetic Pulmonary Surfactants
4.2.2 Animal Derived Surfactants
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 laboratory
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Synthetic Pulmonary Surfactants
5.2.2 Animal Derived Surfactants
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 laboratory
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Synthetic Pulmonary Surfactants
6.2.2 Animal Derived Surfactants
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 laboratory
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Synthetic Pulmonary Surfactants
7.2.2 Animal Derived Surfactants
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 laboratory
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Synthetic Pulmonary Surfactants
8.2.2 Animal Derived Surfactants
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 laboratory
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Synthetic Pulmonary Surfactants
9.2.2 Animal Derived Surfactants
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 laboratory
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Boehringer Ingelheim
10.1.2 AbbVie
10.1.3 Lyomark Pharma
10.1.4 Tekzima (Noargen)
10.1.5 ONY Biotech
10.1.6 Abbott
10.1.7 Aviva Systems Biology
10.1.8 LSBio
10.1.9 Biomatik
10.1.10 Biorbyt
10.1.11 Reddot Biotech
10.1.12 XpressBio
10.1.13 Creative Diagnostics
10.1.14 Nanjing Norris Pharm Technology
10.1.15 Windtree Therapeutics
10.2 Pulmonary Surfactant Sales Date of Major Players (2017-2020e)
10.2.1 Boehringer Ingelheim
10.2.2 AbbVie
10.2.3 Lyomark Pharma
10.2.4 Tekzima (Noargen)
10.2.5 ONY Biotech
10.2.6 Abbott
10.2.7 Aviva Systems Biology
10.2.8 LSBio
10.2.9 Biomatik
10.2.10 Biorbyt
10.2.11 Reddot Biotech
10.2.12 XpressBio
10.2.13 Creative Diagnostics
10.2.14 Nanjing Norris Pharm Technology
10.2.15 Windtree Therapeutics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table 1.Table Pulmonary Surfactant Product Type Overview 2.Table Pulmonary Surfactant Product Type Market Share List 3.Table Pulmonary Surfactant Product Type of Major Players 4.Table Brief Introduction of Boehringer Ingelheim 5.Table Brief Introduction of AbbVie 6.Table Brief Introduction of Lyomark Pharma 7.Table Brief Introduction of Tekzima (Noargen) 8.Table Brief Introduction of ONY Biotech 9.Table Brief Introduction of Abbott 10.Table Brief Introduction of Aviva Systems Biology 11.Table Brief Introduction of LSBio 12.Table Brief Introduction of Biomatik 13.Table Brief Introduction of Biorbyt 14.Table Brief Introduction of Reddot Biotech 15.Table Brief Introduction of XpressBio 16.Table Brief Introduction of Creative Diagnostics 17.Table Brief Introduction of Nanjing Norris Pharm Technology 18.Table Brief Introduction of Windtree Therapeutics 19.Table Products & Services of Boehringer Ingelheim 20.Table Products & Services of AbbVie 21.Table Products & Services of Lyomark Pharma 22.Table Products & Services of Tekzima (Noargen) 23.Table Products & Services of ONY Biotech 24.Table Products & Services of Abbott 25.Table Products & Services of Aviva Systems Biology 26.Table Products & Services of LSBio 27.Table Products & Services of Biomatik 28.Table Products & Services of Biorbyt 29.Table Products & Services of Reddot Biotech 30.Table Products & Services of XpressBio 31.Table Products & Services of Creative Diagnostics 32.Table Products & Services of Nanjing Norris Pharm Technology 33.Table Products & Services of Windtree Therapeutics 34.Table Market Distribution of Major Players 35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 37.Table Global Pulmonary Surfactant Market Forecast (Million USD) by Region 2021f-2026f 38.Table Global Pulmonary Surfactant Market Forecast (Million USD) Share by Region 2021f-2026f 39.Table Global Pulmonary Surfactant Market Forecast (Million USD) by Demand 2021f-2026f 40.Table Global Pulmonary Surfactant Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure 1.Figure Global Pulmonary Surfactant Market Size under the Impact of COVID-19, 2017-2021f (USD Million) 2.Figure Global Pulmonary Surfactant Market by Region under the Impact of COVID-19, 2017-2021f (USD Million) 3.Figure Global Pulmonary Surfactant Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million) 4.Figure Global Pulmonary Surfactant Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million) 5.Figure Global Pulmonary Surfactant Production by Region under the Impact of COVID-19, 2021-2026 (USD Million) 6.Figure Global Pulmonary Surfactant Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million) 7.Figure Global Pulmonary Surfactant Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million) 8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 13.Figure Synthetic Pulmonary Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 14.Figure Animal Derived Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 15.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 16.Figure laboratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 21.Figure Synthetic Pulmonary Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 22.Figure Animal Derived Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 23.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 24.Figure laboratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 25.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 31.Figure Synthetic Pulmonary Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 32.Figure Animal Derived Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 33.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 34.Figure laboratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 43.Figure Synthetic Pulmonary Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 44.Figure Animal Derived Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 45.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 46.Figure laboratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 51.Figure Synthetic Pulmonary Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 52.Figure Animal Derived Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 53.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 54.Figure laboratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 60.Figure Synthetic Pulmonary Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 61.Figure Animal Derived Surfactants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 62.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 63.Figure laboratory Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 64.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 65.Figure Pulmonary Surfactant Sales Revenue (Million USD) of Boehringer Ingelheim 2017-2020e 66.Figure Pulmonary Surfactant Sales Revenue (Million USD) of AbbVie 2017-2020e 67.Figure Pulmonary Surfactant Sales Revenue (Million USD) of Lyomark Pharma 2017-2020e 68.Figure Pulmonary Surfactant Sales Revenue (Million USD) of Tekzima (Noargen) 2017-2020e 69.Figure Pulmonary Surfactant Sales Revenue (Million USD) of ONY Biotech 2017-2020e 70.Figure Pulmonary Surfactant Sales Revenue (Million USD) of Abbott 2017-2020e 71.Figure Pulmonary Surfactant Sales Revenue (Million USD) of Aviva Systems Biology 2017-2020e 72.Figure Pulmonary Surfactant Sales Revenue (Million USD) of LSBio 2017-2020e 73.Figure Pulmonary Surfactant Sales Revenue (Million USD) of Biomatik 2017-2020e 74.Figure Pulmonary Surfactant Sales Revenue (Million USD) of Biorbyt 2017-2020e 75.Figure Pulmonary Surfactant Sales Revenue (Million USD) of Reddot Biotech 2017-2020e 76.Figure Pulmonary Surfactant Sales Revenue (Million USD) of XpressBio 2017-2020e 77.Figure Pulmonary Surfactant Sales Revenue (Million USD) of Creative Diagno